98 studies found for:    "Olmesartan medoxomil"
Show Display Options
Rank Status Study
1 Completed
Has Results
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure
Condition: Hypertension
Interventions: Drug: olmesartan medoxomil;   Drug: placebo
2 Completed
Has Results
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
Condition: Essential Hypertension
Interventions: Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo;   Drug: Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo;   Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide;   Drug: olmesartan medoxomil + amlodipine
3 Completed
Has Results
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
Condition: Essential Hypertension
Interventions: Drug: Olmesartan medoxomil 40 mg - Amlodipine 10 mg;   Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg;   Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg;   Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg;   Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
4 Completed Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
Conditions: Metabolic Syndrome;   Hypertension
Interventions: Drug: Olmesartan medoxomil tablets low dose;   Drug: Olmesartan medoxomil tablets high dose;   Drug: Amlodipine
5 Completed
Has Results
Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo;   Drug: olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets;   Drug: olmesartan medoxomil/hydrochlorothiazide tablets
6 Completed
Has Results
Olmesartan Comparison to Losartan in Hypertensive Subjects
Condition: Hypertension
Interventions: Drug: olmesartan medoxomil;   Drug: Placebo;   Drug: losartan potassium
7 Completed Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease.
Condition: Safety
Interventions: Drug: Azilsartan medoxomil and chlorthalidone;   Drug: Olmesartan medoxomil and hydrochlorothiazide
8 Completed Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: olmesartan medoxomil + hydrochlorothiazide;   Drug: olmesartan medoxomil
9 Completed The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)
Condition: Hypertension
Interventions: Drug: Olmesartan medoxomil +Azelnidipine;   Drug: Olmesartan medoxomil + Hydrochlorothiazide
10 Completed Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
Conditions: Metabolic Syndrome;   Hypertension
Interventions: Drug: olmesartan medoxomil;   Drug: placebo
11 Completed
Has Results
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes
Condition: Hypertension
Interventions: Drug: olmesartan medoxomil;   Drug: Olmesartan medoxomil plus Hydrochlorothiazide
12 Completed
Has Results
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: Azilsartan medoxomil and chlorthalidone;   Drug: Olmesartan medoxomil and hydrochlorothiazide
13 Completed
Has Results
Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension
Condition: Hypertension
Interventions: Drug: olmesartan medoxomil and a CCB;   Drug: olmesartan medoxomil and a diuretic
14 Completed
Has Results
Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets;   Drug: olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
15 Completed Olmesartan in Essential Hypertension
Condition: Essential Hypertension
Interventions: Other: placebo;   Drug: olmesartan medoxomil;   Drug: olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets
16 Completed
Has Results
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
Condition: Hypertension
Interventions: Drug: Azilsartan medoxomil and olmesartan;   Drug: Olmesartan;   Drug: Placebo
17 Completed
Has Results
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
Condition: Essential Hypertension
Interventions: Drug: Azilsartan medoxomil and chlorthalidone;   Drug: Olmesartan medoxomil and hydrochlorothiazide
18 Completed Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg
Condition: Healthy
Interventions: Drug: Olmesartan Medoxomil Tablets 40 mg;   Drug: Benicar® Tablets 40 mg
19 Completed Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg
Condition: Healthy
Interventions: Drug: Olmesartan Medoxomil Tablets 40 mg;   Drug: Benicar® Tablets 40 mg
20 Completed Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg
Condition: Healthy
Interventions: Drug: Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg;   Drug: Benicar HCT® Tablets 40 mg/25 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years